Abstract: The invention relates to a process for making single phase dilution thickening compositions comprising electrolyte. By adding defined associative thickener to said compositions applicants have found one can lower level of salt/electrolyte required to obtain dilution thickening effect.

Abstract: A fiber-based source for high-energy picosecond and nanosecond pulses is described. By minimizing nonlinear energy limitations in fiber amplifiers, pulse energies close to the damage threshold of optical fibers can be generated. The implementation of optimized seed sources in conjunction with amplifier chains comprising at least one nonlinear fiber amplifier allows for the generation of near bandwidth-limited high-energy picosecond pulses. Optimized seed sources for high-energy pulsed fiber amplifiers comprise semiconductor lasers as well as stretched mode locked fiber lasers. The maximization of the pulse energies obtainable from fiber amplifiers further allows for the generation of high-energy ultraviolet and IR pulses at high repetition rates.

Abstract: The invention relates to stable aqueous-aqueous emulsions defined by a dispersed phase having molecule(s) meeting special criteria and continuous phase having surfactant or surfactant system with micelles in rod-like shapes.

Abstract: The invention relates to single phase dilution thickening compositions both electrolyte and associative thickener. The two act synergistically to lower level of salt required for thickening to provide high viscosity retention and to provide a cohesitivity perceived by consumers as improved retention.

Abstract: The present invention provides compositions, methods, and kits for administration of nalmefene for treatment of alcoholism, nicotine dependence, or another condition for which treatment with nalmefene is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases nalmefene continuously with generally linear release kinetics for extended periods of time. Nalmefene is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with nalmefene.

Abstract: The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.

Abstract: The present composition comprises bars having small amounts of surfactant and high amounts of sugars which bar maintains good rates of wear and foams adequately. The sugar has unexpectedly been found to structure bars, even when little or no insoluble fatty acid is used, without degrading bar properties. Further, the invention comprises a process for making such bars which are white and consumer desirable.

Abstract: The present composition comprises bar having small amounts of surfactant and high amounts of sugars which bar maintains good rates of wear and foams adequately. The sugar has unexpectedly been found to structure bars, even when little or no insoluble fatty acid is used, without degrading bar properties.

Abstract: The invention relates to use of specifically defined polydextrose to induce biphasic liquid formation. Optional use of salt allows less polydextrose to be used to induce biphasic formation.

Abstract: The invention relates to use of specifically defined polydextrose to induce biphasic liquid formation. Optional use of salt allows less polydextrose to be used to induce biphasic formation.

Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.

Abstract: The present invention relates to the use of multiple store buffer forwarding in a microprocessor system with a restrictive memory model. In accordance with an embodiment of the present invention, the system and method allow load operations that are completely covered by two or more store operations to receive data via store buffer forwarding in such a manner as to retain the side effects of the restrictive memory model thereby increasing processor performance without violating the restrictive memory model.

Abstract: The present invention relates to a method for detecting the amount of a target polynucleotide in a sample. A combination is provided in a medium. The combination comprises (i) a sample suspected of containing the target polynucleotide, the target polynucleotide being in single stranded form, (ii) a reference polynucleotide comprising a sequence that is common with a sequence of the target polynucleotide, and (iii) a predetermined amount of an oligonucleotide probe that has a sequence that hybridizes with the sequence that is common. The combination is subjected to conditions for amplifying the target polynucleotide and the reference polynucleotide. The conditions permit formation of substantially non-dissociative complexes of the target polynucleotide and the reference polynucleotide, respectively, with the oligonucleotide probe. Furthermore, the predetermined amount of the oligonucleotide probe is less than the expected amount of the amplified target polynucleotide.

Abstract: The present invention relates to locked memory instructions, and more specifically to a system and method for the high performance execution of locked memory instructions in a system with distributed memory and a restrictive memory model. In accordance with an embodiment of the present invention, a method for executing locked-memory instructions includes decoding a locked-memory instruction, obtaining exclusive ownership of a cacheline to be used by a load-lock operation, setting a bit to indicate the load-lock operation's ownership of the cacheline, and activating a snoop checking process. The method also includes modifying a load data value and storing the modified load data value. The method further includes determining that the cacheline is still exclusively owned, storing the load data value, determining that the cacheline is unsnooped, merging the modified load data value with the load data value, and releasing the locked-memory instruction to be retired.

Abstract: The present invention relates to a method for detecting the amount of a target polynucleotide in a sample. A combination is provided in a medium. The combination comprises (i) a sample suspected of containing the target polynucleotide, the target polynucleotide being in single stranded form, (ii) a reference polynucleotide comprising a sequence that is common with a sequence of the target polynucleotide, and (iii) a predetermined amount of an oligonucleotide probe that has a sequence that hybridizes with the sequence that is common. The combination is subjected to conditions for amplifying the target polynucleotide and the reference polynucleotide. The conditions permit formation of substantially non-dissociative complexes of the target polynucleotide and the reference polynucleotide, respectively, with the oligonucleotide probe. Furthermore, the predetermined amount of the oligonucleotide probe is less than the expected amount of the amplified target polynucleotide.

Abstract: The present invention relates to the composition comprising soap and alkoxylated triglyceride wherein said bars have improved sensory properties (e.g., reduced drag and stickiness; and enhanced slipperiness) relative to identical bar with non-alkoxylated triglyceride.

Abstract: A method and apparatus for dual-target register allocation is described, intended to enable the efficient mapping/renaming of registers associated with instructions within a pipelined microprocessor architecture.

Abstract: The present invention relates to a method for detecting the amount of a target polynucleotide in a sample. A combination is provided in a medium. The combination comprises (i) a sample suspected of containing the target polynucleotide, the target polynucleotide being in single stranded form, (ii) a reference polynucleotide comprising a sequence that is common with a sequence of the target polynucleotide, and (iii) a predetermined amount of an oligonucleotide probe that has a sequence that hybridizes with the sequence that is common. The combination is subjected to conditions for amplifying the target polynucleotide and the reference polynucleotide. The conditions permit formation of substantially non-dissociative complexes of the target polynucleotide and the reference polynucleotide, respectively, with the oligonucleotide probe. Furthermore, the predetermined amount of the oligonucleotide probe is less than the expected amount of the amplified target polynucleotide.

Abstract: An electronic device including a predictor that has a collision history table (CHT) is presented. An extended load buffer is connected to the predictor. Also included is a marking unit, a comparing unit and a recovery unit connected to the extended load buffer. Unexecuted load instructions are advanced over store instructions. Also presented is a method for fetching an instruction and determining if an instruction is a store or a load. If the instruction is a store, then the method performs a silent store prediction. If the instruction is a load, a predicted silent store instruction is bypassed and the load instruction is executed.

Abstract: A controlled release medicament delivery system comprises a plasticized bioerodible polymer, such as a polyorthoester. Medicament desirably is entrapped in the plasticized polymer. The resulting delivery system is able to release the medicament in a controlled and sustained manner. The formulation is particularly advantageous for use as a once-a-day eyedrop. During preparation, the polymer may be heated to an elevated temperature for a sufficient time to substantially reduce its molecular weight.